Skip to main content

Table 2 Quality assessment of included articles

From: Additional cost of end-stage kidney disease in diabetic patients according to renal replacement therapy modality: a systematic review

Author

Year

Design

Prospective

Retrospective

Data source

Comorbidities definition

Confounder

Adjustment

Selection

Comparability

Outcome

Total

Source diversity

Sample size

Missing data

Exposure Analysis

Main factor

Other factors

Evaluation

Stat test

Li et al. [11, 22]

2015

Cross-sectional

Retrospective

National

Discharge codes from hospitalizations prior to starting RRT-ICD 10

None

None

*

*

 

*

  

*

*

5

2016

 

MRM

Age, sex, years since starting RRT, treatment modality, events, comorbidities

*

*

  

*

*

*

*

6

Grun et al. [23]

2003

Cohort

Prospective

4 dialysis units

At baseline

None

Sex, age, treatment modality, comorbid conditions, cohort, length of time since initiation

    

*

*

*

*

4

Kao et al. [24]

2013

Cohort

Retrospective

National

 

Stratification

Stratification by matched HD-PD on age, sex, DM status

*

*

    

*

 

3

Su et al. [25]

2010

Cross-sectional

Prospective

One district

 

MRM

Comorbidities, age

    

*

 

*

*

3

Yang et al. [26]

2001

Cross-sectional

Prospective

3 medical centers

 

Matching

Matched DM–no DM on age, sex, duration of dialysis

    

*

 

*

 

2

Hynes et al. [27]

2012

Cohort

Prospective

Veterans Affairs facilities

Year prior the index date-ICD 9

MRM

Age, gender, race, income, insurance, comorbidities, quality of well-being

   

*

*

*

*

*

5

Bruns et al. [28]

1997

Cross-sectional

Retrospective

1 medical center

 

Stratification

Stratification by age

      

*

 

1

Salonen et al. [29]

2003

Cohort

Prospective

1 medical center

 

MRM

Stratification by treatment modality

      

*

*

2

Couillerot et al. [30]

2017

Cross-sectional

Retrospective

National

Use of drugs for DM

Stratification

Stratification on age and RRT modality, events

*

*

 

*

  

*

 

4

Icks et al. [31]

2010

Cross-sectional

Prospective

1 medical center

 

MRM

Gender, age, ESKD duration, time of dialysis

    

*

 

*

*

3

Joyce et al. [32]

2004

Cohort

Retrospective

Commercially insured patients in 61 Health Plans

Year prior the index date-ICD 9

MRM

Age, gender, insurance, comorbidities, region, medication use. No adjustment on RRT modality.

 

*

 

*

  

*

*

4

Mau et al. [33]

2010

Cohort

Retrospective

National

2 years prior the index date-ICD 9

MRM

Age, gender, race, comorbidities, Hb, eGFR, albumin, BMI, hospital days pre-onset

*

*

 

*

*

 

*

*

6

Ghoddousi et al. [35]

2007

Cross-sectional

Retrospective

1 medical center

Reported in the EMR

None

None

 

*

 

*

  

*

 

3

Smith et al. [36]

1989

Cohort

Retrospective

Michigan database

 

None

None

*

*

  

*

   

3

Woodward et al. [37]

2011

Cohort

Retrospective

US Renal Data System

ICD 9

None

None

*

*

 

*

*

 

*

*

6

Wong et al. [34]

2012

Cohort

Retrospective

National

Australian Refined Diagnosis Related Groups

Stratification

None

*

  

*

*

*

*

 

5

Manley et al. [38]

2005

Cross-sectional

Retrospective

National

 

None

None

*

*

  

*

 

*

 

4

  1. * used to mark the charateristic as present in the study
  2. MRM multiple regression model, RRT renal replacement therapy, ESKD end-stage kidney disease